Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism

Author：                    

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.5, Iss.3, 2012-01, pp. : 729-733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease

By                    

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1077-1081

Spandidos Publications

Access to resources Recommend Favorite

Association between metabolic syndrome and the development of non-alcoholic fatty liver disease

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 77-84

Spandidos Publications

Access to resources Recommend Favorite

Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c

By        

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 815-820

Spandidos Publications

Access to resources Recommend Favorite

Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway

By        

Experimental and Therapeutic Medicine, Vol. 11, Iss. 1, 2016-01 ,pp. : 73-76

Spandidos Publications

Access to resources Recommend Favorite

A case–control study of non-alcoholic fatty liver disease in breast cancer

By Bilici Ahmet   Ozguroglu Mustafa   Mihmanlı İsmail   Turna Hande   Adaletli İbrahim  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 367-371

Humana Press, Inc

Access to resources Recommend Favorite